Responses

PDF

Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

PLEASE NOTE:

  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Susceptibility to ocular autoimmune disease
    • , Ophthalmologist
    • Other Contributors:
      • C E Egwuagu, P Charukamnoetkanok, I Gery

    Editor,
    We read with interest the Newsdesk piece in the March 2000 issue of the journal, commenting on recent studies indicating a conceptual shift in the understanding of the molecular basis of differential susceptibility to organ-specific autoimmune diseases. However, we were disappointed that the Newsdesk piece was restricted to studies of the animal model of multiple sclerosis and not that of uveitis....

    Show More
    Conflict of Interest:
    None declared.